Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Opioid Reduction Toolkit in Pancreatectomy Patients
NCT05363436Phase 4Suspended
- Sponsor
- Thomas Jefferson University
- Start
- Jan 2018
- Primary completion
- Dec 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of oxycodone in pain and opioid use disorder (OUD), sponsored by Thomas Jefferson University. Primary endpoints: Number of opioid pills reported being taken by the patient at 14 days and Number of opioid pills being prescribed at 14 days. Started Jan 2018; status: suspended.
02
Drugs
oxycodone
03
Conditions
painopioid use disorder (OUD)
Beyond the preview
Go deeper on NCT05363436.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05363436.